143 related articles for article (PubMed ID: 1821700)
1. Interest of a loading dose of milnacipran in endogenous depressive inpatients. Comparison with the standard regimen and with fluvoxamine.
Ansseau M; von Frenckell R; Gérard MA; Mertens C; De Wilde J; Botte L; Devoitille JM; Evrard JL; De Nayer A; Darimont P
Eur Neuropsychopharmacol; 1991 May; 1(2):113-21. PubMed ID: 1821700
[TBL] [Abstract][Full Text] [Related]
2. Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients.
Ansseau M; von Frenckell R; Mertens C; de Wilde J; Botte L; Devoitille JM; Evrard JL; De Nayer A; Darimont P; Dejaiffe G
Psychopharmacology (Berl); 1989; 98(2):163-8. PubMed ID: 2569214
[TBL] [Abstract][Full Text] [Related]
3. Controlled comparison of milnacipran and fluoxetine in major depression.
Ansseau M; Papart P; Troisfontaines B; Bartholomé F; Bataille M; Charles G; Schittecatte M; Darimont P; Devoitille JM; De Wilde J
Psychopharmacology (Berl); 1994 Feb; 114(1):131-7. PubMed ID: 7846195
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine.
Clerc G;
Int Clin Psychopharmacol; 2001 May; 16(3):145-51. PubMed ID: 11354236
[TBL] [Abstract][Full Text] [Related]
6. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
Isaac MT; Isaac MB; Gallo F; Tournoux A
Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study.
Fukuchi T; Kanemoto K
Int Clin Psychopharmacol; 2002 Mar; 17(2):53-8. PubMed ID: 11890186
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients.
Guelfi JD; Ansseau M; Corruble E; Samuelian JC; Tonelli I; Tournoux A; Plétan Y
Int Clin Psychopharmacol; 1998 May; 13(3):121-8. PubMed ID: 9690979
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients.
Naito S; Sato K; Yoshida K; Higuchi H; Takahashi H; Kamata M; Ito K; Ohkubo T; Shimizu T
Psychiatry Clin Neurosci; 2007 Aug; 61(4):421-7. PubMed ID: 17610668
[TBL] [Abstract][Full Text] [Related]
10. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
Higuchi H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):71-6. PubMed ID: 20491280
[TBL] [Abstract][Full Text] [Related]
11. The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.
Yoshida K; Higuchi H; Kamata M; Takahashi H; Inoue K; Suzuki T; Itoh K; Ozaki N
J Psychopharmacol; 2007 Aug; 21(6):650-6. PubMed ID: 17092970
[TBL] [Abstract][Full Text] [Related]
12. Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depression.
Takahashi H; Yoshida K; Higuchi H; Kamata M; Inoue K; Suzuki T; Ishigooka J
Neuropsychobiology; 2014; 70(3):173-80. PubMed ID: 25358426
[TBL] [Abstract][Full Text] [Related]
13. A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder.
Steen A; Den Boer JA
Int Clin Psychopharmacol; 1997 Sep; 12(5):269-81. PubMed ID: 9466161
[TBL] [Abstract][Full Text] [Related]
14. Controlled comparison of two different doses of milnacipran in major depressive outpatients.
Kanemoto K; Matsubara M; Yamashita K; Tarao Y; Inada E; Sekine T
Int Clin Psychopharmacol; 2004 Nov; 19(6):343-6. PubMed ID: 15486520
[TBL] [Abstract][Full Text] [Related]
15. A randomised, double-blind comparison of milnacipran and imipramine in the treatment of depression.
Van Amerongen AP; Ferrey G; Tournoux A
J Affect Disord; 2002 Oct; 72(1):21-31. PubMed ID: 12204314
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of milnacipran: placebo-controlled trials.
Lecrubier Y; Pletan Y; Solles A; Tournoux A; Magne V
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():29-33. PubMed ID: 8923124
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
Kasper S; Pletan Y; Solles A; Tournoux A
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
[TBL] [Abstract][Full Text] [Related]
18. Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression.
Morishita S; Arita S
Hum Psychopharmacol; 2003 Aug; 18(6):479-82. PubMed ID: 12923828
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric comorbidities and use of milnacipran in patients with chronic dizziness.
Horii A; Imai T; Kitahara T; Uno A; Morita Y; Takahashi K; Inohara H
J Vestib Res; 2016 Jul; 26(3):335-40. PubMed ID: 27392838
[TBL] [Abstract][Full Text] [Related]
20. Subjective and polysomnographic effects of milnacipran on sleep in depressed patients.
Lemoine P; Faivre T
Hum Psychopharmacol; 2004 Jul; 19(5):299-303. PubMed ID: 15252822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
